Rare inflammatory disease responds best to the one-two punch of JAK inhibition (IMAGE)

St. Jude Children's Research Hospital

Rare inflammatory disease responds best to the one-two punch of JAK inhibition

Caption

Corresponding author Kim Nichols, MD, St. Jude Division of Cancer Predisposition director, a part of the Department of Oncology.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.